COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,196 Articles (22,713 medRxiv, 8,483 bioRxiv)

Most recent first Previous |  Page 1633: Articles 16321-16330  | Next

Industry and workplace characteristics associated with the use of a COVID-19 contact tracing app in Japan: a nation-wide employee survey
Ishimaru, T., Ibayashi, K., Nagata, M., Hino, A., Tateishi, S., Tsuji, M., Ogami, A., Matsuda, S., Fujino, Y.
10.1101/2021.04.01.21254744 — Posted: 2021-04-07
Impact of a nighttime curfew on overnight mobility
Ghasemi, A., Daneman, N., Berry, I., Buchan, S. A., Soucy, J.-P., Sturrock, S., Brown, K. A.
10.1101/2021.04.04.21254906 — Posted: 2021-04-07
Higher Relative Viral Load Excretion Determined by Normalised Threshold Crossing Value in Acute Cases infected with the B.1.1.7 Lineage VOC 202012/01 (Using S gene target failure as a Proxy) When Compared to other Circulating Lineages in Wales
Couzens, A., Murrell, I., Johns, B., Pheasant, K., Turner, L., Evans, J., Moore, C., Gifford, L.
10.1101/2021.04.02.21254832 — Posted: 2021-04-07
Comparing between survived and deceased patients with Diabetes Mellitus and COVID-19 in Bangladesh: A cross- sectional study from COVID-19 dedicated hospital
Morshed, M. S., Mosabbir, A. A., Hossain, M. S.
10.1101/2021.04.04.21254884 — Posted: 2021-04-07
Sex and gender differences in COVID testing, hospital admission, presentation, and drivers of severe outcomes in the DC/Maryland region
Scully, E. P., Schumock, G., Fu, M., Massaccesi, G., Muschelli, J., Betz, J., Klein, E. Y., West, N. E., Robinson, M. L., Garibaldi, B. T., Bandeen- Roche, K., Zeger, S., Klein, S. L., Gupta, A.
10.1101/2021.04.05.21253827 — Posted: 2021-04-07
Unraveling Attributes of COVID-19 Vaccine Hesitancy in the U.S.: A Large Nationwide Study
McCabe, S., Hammershaimb, E. A. D., Cheng, D., Shi, A., Shyr, D., Shen, S., Cole, L. D., Cataldi, J. R., Allen, W., Probasco, R., Silbermann, B., Zhang, F., Marsh, R., Travassos, M., Lin, X.
10.1101/2021.04.05.21254918 — Posted: 2021-04-07 Discussion: Onsite
Evaluation of the performance of SARS-CoV-2 antibody assays for the longitudinal population-based study of COVID-19 spread in St. Petersburg, Russia
Barchuk, A., Shirokov, D., Sergeeva, M., Tursun-zade, R., Dudkina, O., Tychkova, V., Barabanova, L., Skougarevskiy, D., Danilenko, D.
10.1101/2021.04.05.21254712 — Posted: 2021-04-07
Levels of produced antibodies after vaccination with mRNA vaccine; effect of previous infection with SARS-CoV-2
Konstantinidis, T., Zisaki, S., Mitroulis, I., Konstantinidou, E., Kontekaki, E. G., Romanidou, G., Karvelas, A., Nanousi, I., Lazidis, L., Cassimos, D., Tsigalou, C., Martinis, G., Panopoulou, M.
10.1101/2021.04.05.21254934 — Posted: 2021-04-07
Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19
Klaric, L., Gisby, J. S., Papadaki, A., Muckian, M. D., Macdonald-Dunlop, E., Zhao, J. H., Tokolyi, A., Persyn, E., Pairo-Castineira, E., Morris, A. P., Kalnapenkis, A., Richmond, A., Landini, A., Hedman, A. K., Prins, B., Zanetti, D., Wheeler, E., Kooperberg, C., Yao, C., Petrie, J. R., Fu, J., Folkersen, L., Walker, M., Magnusson, M., Eriksson, N., Mattsson-Carlgren, N., Timmers, P. R., Hwang, S.-J., Enroth, S., Gustafsson, S., Vosa, U., Chen, Y., Siegbahn, A., Reiner, A., Johansson, A., Thorand, B., Gigante, B., Hayward, C., Herder, C., Gieger, C., Langenberg, C., Levy, D., Zhernakova, D. V., Smith, J. G., Campbell, H., Sundstrom, J., Danesh, J., Michaëlsson, K., Suhre, K., Lind, L., Wallentin, L., Padyukov, L., Landen, M., Wareham, N. J., Göteson, A., Hansson, O., Eriksson, P., Strawbridge, R. J., Assimes, T. L., Esko, T., Gyllensten, U., Baillie, J. K., Paul, D. S., Joshi, P. K., Butterworth, A. S., Mälarstig, A., Pirastu, N., Wilson, J. F., Peters, J. E.
10.1101/2021.04.01.21254789 — Posted: 2021-04-07
Co-circulation of SARS-CoV-2 variants B.1.1.7 and P.1
Stefanelli, P., Trentini, F., Guzzetta, G., Marziano, V., Mammone, A., Poletti, P., Molina Grane', C., Manica, M., del Manso, M., Andrianou, X., Pezzotti, P., Ajelli, M., Rezza, G., Brusaferro, S., Merler, S., COVID-19 National Microbiology Surveillance Study Group
10.1101/2021.04.06.21254923 — Posted: 2021-04-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).